Working... Menu

Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01931644
Recruitment Status : Recruiting
First Posted : August 29, 2013
Last Update Posted : April 18, 2018
Information provided by (Responsible Party):
Sanguine Biosciences

Brief Summary:
At Sanguine, we consider ourselves the bridge between patients and researchers striving to find new treatments and diagnostics for numerous medical conditions. We collect biospecimens such as blood for medical researchers. Donate from your home, track your sample, and help advance medical research.

Condition or disease
All Diagnosed Health Conditions

Detailed Description:
This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 20000 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Study Start Date : July 2013
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : December 2040

Health Condition
Collect blood and other optional biospecimens from participants with a diagnosed health condition
Healthy Control
Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition

Primary Outcome Measures :
  1. Biospecimen & Clinical Data Collection [ Time Frame: 10 years ]
    To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results

Biospecimen Retention:   Samples With DNA
Whole blood, serum, plasma, PBMC, RNA, DNA, saliva, stool, hair, skin, CSF, synovial fuid, tumor tissue, urine

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Diagnosed with a health condition

Inclusion Criteria:

  • All adults 18-100 years old
  • Able to provide proof of diagnosis
  • Live in USA

Exclusion Criteria:

  • Younger than 18 years old
  • Receipt of blood products within 30 days of study blood collection
  • Receipt of investigational drug within 30 days of study blood collection

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01931644

Layout table for location contacts
Contact: Nicole Greenshpun 855-836-4759

Layout table for location information
United States, California
Sanguine Biosciences Recruiting
Los Angeles, California, United States, 91403
Contact: Nicole Greenshpun    855-836-4759   
Principal Investigator: Phil Silkoff, MD         
Sponsors and Collaborators
Sanguine Biosciences
Layout table for investigator information
Principal Investigator: Phil Silkoff, MD Sanguine Biosciences

Layout table for additonal information
Responsible Party: Sanguine Biosciences Identifier: NCT01931644     History of Changes
Other Study ID Numbers: SAN-BB-01
First Posted: August 29, 2013    Key Record Dates
Last Update Posted: April 18, 2018
Last Verified: April 2018

Keywords provided by Sanguine Biosciences:
Graft-versus-Host Disease (GVHD)
Crohn's Disease
Kidney Disease
Alzheimer's Disease
Parkinson's Disease
Huntington's Disease
Amyotrophic Lateral Sclerosis (ALS)
Hepatitis B
Multiple Sclerosis
Ulcerative Colitis
Rheumatoid Arthritis
Sjogren's Syndrome
Idiopathic Thrombocytopenia Purpura
Cystic Fibrosis
Primary Biliary Cirrhosis

Additional relevant MeSH terms:
Layout table for MeSH terms
Alzheimer Disease
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders